Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model

C.F.M. Molthoff, H.M. Pinedo, M.M. Schlüper, E. Boven

Research output: Contribution to journalArticleAcademicpeer-review

2 Downloads (Pure)
Original languageEnglish
Pages (from-to)474-480
JournalInternational Journal of Cancer
Volume50
Publication statusPublished - 1992

Cite this